Skip to main content
Fig. 6 | BMC Medical Genomics

Fig. 6

From: SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer

Fig. 6

Relation of SYNJ2 expression with overall survival and disease-specific survival of cancers patients. A, B SYNJ2 expression is related to overall survival (A) and disease-specific survival (B) of cancers patients based on the results of univariate Cox regression analysis. C, D SYNJ2 expression is related to overall survival (C) and disease-specific survival (D) of cancers patients based on the results of Kaplan–Meier curves

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us